Cipla USA has recalled unexpired batches of Lanreotide Injection, resulting in a temporary market shortage. The recall ...

Cipla USA has recalled over 400 cartons of Nilotinib Capsules used to treat blood cancers after they failed to meet specifications, according to the U.S. Food and Drug Administration, which classified ...

Cipla Limited has announced that it has entered into a 60:40 joint venture agreement with Kemwell Biopharma Private Limited ...

Cipla share price fell 2.4 per cent to the day's low of ₹1,335.90 per share on the National Stock Exchange (NSE) ...

Fennec Pharmaceuticals Inc. (NASDAQ:FENC; TSX: FRX), a specialty pharmaceutical company, today announces that it has entered into an agreement with Cipla Limited and Cipla USA, Inc. to settle the ...

Cipla Ltd is quoting at Rs 1286.4, down 1.05% on the day as on 13:19 IST on the NSE. The stock tumbled 14.73% in last one year as compared to a 3.15% rally in NIFTY and a 7.68% spurt in the Nifty ...

Cipla USA, a subsidiary of the Indian drugmaker, is recalling over 400 cartons of generic anti-cancer drug Nilotinib due to a manufacturing issue. The recall is classified as Class III by the USFDA, ...

More than 400 cartons of Nilotinib capsules were voluntarily recalled by Cipla USA after failing manufacturing specifications ...

Pharma stocks have made a big comeback in recent months, with companies such as Granules India, Gland Pharma, Dr. Reddy's Laboratories, Natco Pharma, Aurobindo Pharma, and Cipla rebounding sharply ...

A US-based subsidiary of Cipla has recalled more than 400 cartons of a generic anti-cancer medication from the American market after a manufacturing-related issue was detected, according to the US ...

Pharma Tariff Impact On Stocks: Pharma stocks fell sharply on Friday (September 26) following Donald Trump's decision to impose 100 per cent tariffs on branded drugs. The Nifty Pharma index opened ...